Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma

NCT00323739 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: bevacizumab
DRUG: RAD001

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]